© 2003 Fellowship of Postgraduate Medicine
REVIEW
Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes) syndrome
Correspondence to:
Correspondence to:
Dr Graham Hughes, Lupus Unit, St Thomas Hospital, London SE1 7EH;
graham.hughes{at}kcl.ac.uk
The antiphospholipid syndrome (APS, Hughes syndrome), first described in 1983, is a prothrombotic disease in which neurological events feature prominently. Strokes, transient ischaemic attacks, and headaches (including migraine) are important complications. However, it is clear that other neurological symptoms, including diplopia, memory loss, ataxia, and "multiple sclerosis-like" features are common. A notable feature of Hughes syndrome is the clinical response to anticoagulants; features such as headache and memory loss often improving dramatically with appropriate warfarin dosage. APS may well become recognised as an important (and potentially treatable) cause of neurological disease.
Keywords: antiphospholipid syndrome; Hughes syndrome; migraine; memory loss; "multiple sclerosis"
Abbreviations: APS, antiphospholipid syndrome; INR, international normalised ratio
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Raza, H., Epstein, S. A., Pao, M., Rosenstein, D. L.
(2008). Mania: Psychiatric Manifestations of the Antiphospholipid Syndrome. Psychosomatics
49: 438-441
[Abstract] [Full Text] -
Theodoridou, A, Settas, L
(2008). Demyelination in rheumatic diseases. Postgrad. Med. J.
84: 127-132
[Abstract] [Full Text] -
Theodoridou, A, Settas, L
(2006). Demyelination in rheumatic diseases.. J. Neurol. Neurosurg. Psychiatry
77: 290-295
[Abstract] [Full Text] -
Bertolaccini, M L, Khamashta, M A
(2006). Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus
15: 172-178
[Abstract] -
Krause, I, Lev, S, Fraser, A, Blank, M, Lorber, M, Stojanovich, L, Rovensky, J, Chapman, J, Shoenfeld, Y
(2005). Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis
64: 1490-1493
[Abstract] [Full Text] -
Ruiz-Irastorza, G., Khamashta, M. A.
(2005). Stroke and antiphospholipid syndrome: the treatment debate. Rheumatology (Oxford)
44: 971-974
[Abstract] [Full Text] -
Ferreira, S., D'Cruz, D. P., Hughes, G. R. V.
(2005). Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?. Rheumatology (Oxford)
44: 434-442
[Abstract] [Full Text] -
D'Cruz, D., Hughes, G. R.V.
(2003). Lupus and the nervous system. Lupus
12: 871-871
-
Sinharay, R
(2003). Sneddon's syndrome: additional neurological feature in antiphospholipid (Hughes') syndrome. Postgrad. Med. J.
79: 550-550
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
